Literature DB >> 2724869

Treatment of secretory diarrhea in AIDS with the somatostatin analogue SMS 201-995.

H S Füessl1, W G Zoller, M M Kochen, J R Bogner, B Heinrich, A Matuschke, F D Goebel.   

Abstract

We have observed two patients with AIDS suffering from severe watery diarrhea refractory to conventional medical treatment. In the first patient the reason for the diarrhea could not be revealed in spite of extensive investigations; however, the clinical picture suggested cryptosporidia infection. In the second patient cytomegalovirus could be shown in colonic biopsy specimens. After failure of several attempts of symptomatic, antibiotic, and antiviral therapy, the long-acting somatostatin analogue SMS 201-995 was administered to the patients subcutaneously in a dose between 2 x 50 micrograms and 3 x 100 micrograms/day. This treatment resulted in a prompt reduction of stool volume and bowel motions. Somatostatin may be a useful addition to the symptomatic treatment of refractory diarrhea in AIDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2724869     DOI: 10.1007/bf01725142

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy.

Authors:  P D Smith; H C Lane; V J Gill; J F Manischewitz; G V Quinnan; A S Fauci; H Masur
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

2.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

3.  Somatostatin treatment for cryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS).

Authors:  D J Cook; J G Kelton; A M Stanisz; S M Collins
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

4.  Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.

Authors:  H S Fuessl; G Carolan; G Williams; S R Bloom
Journal:  Digestion       Date:  1987       Impact factor: 3.216

5.  Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera.

Authors:  P N Maton; T M O'Dorisio; B A Howe; K E McArthur; J M Howard; J A Cherner; T B Malarkey; M J Collen; J D Gardner; R T Jensen
Journal:  N Engl J Med       Date:  1985-01-03       Impact factor: 91.245

6.  Prolonged treatment of Zollinger-Ellison syndrome by long-acting somatostatin.

Authors:  S Bonfils; P Ruszniewski; V Costil; H Laucournet; J Vatier; E Rene; M Mignon
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

7.  Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea.

Authors:  N S Williams; J C Cooper; A T Axon; R F King; M Barker
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-20

Review 8.  Treatment of patients with acquired immunodeficiency syndrome and associated manifestations.

Authors:  L D Kaplan; C B Wofsy; P A Volberding
Journal:  JAMA       Date:  1987-03-13       Impact factor: 56.272

9.  Cytoprotective properties of somatostatins.

Authors:  K H Usadel; H Kessler; G Rohr; K Kusterer; K D Palitzsch; U Schwedes
Journal:  Klin Wochenschr       Date:  1986

10.  Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.

Authors:  M Sheppard; B Shapiro; B Pimstone; S Kronheim; M Berelowitz; M Gregory
Journal:  J Clin Endocrinol Metab       Date:  1979-01       Impact factor: 5.958

View more
  1 in total

1.  Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia.

Authors:  Siham Al Sinani; Yusria Al Rawahi; Hamed Abdoon
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.